Healthcare - Biotechnology - NASDAQ - US
$ 0.4906
-5.83 %
$ 20.3 M
Market Cap
-0.52
P/E
INCOME STATEMENT
10.1 M
REVENUE
-52 M
OPERATING INCOME
-47.9 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Spruce Biosciences, Inc.
| Revenue | 10.1 M |
| Cost Of Revenue | 49.4 M |
| Gross Profit | -39.3 M |
| Operating Expenses | 62.1 M |
| Operating Income | -52 M |
| Other Expenses | -4.07 M |
| Net Income | -47.9 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 10.1 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 49.4 | 0.4 | 0.4 | 0.1 | 12 K | 1 K |
| Gross Profit | (39.3) | (0.4) | (0.4) | (0.1) | 12 K | 1 K |
| OPERATING INCOME | ||||||
| Operating Expenses | 62.1 | 47.3 | 42.1 | 29.4 | 13.1 | 10.0 |
| Selling, General and Administrative Expenses | 12.7 | 12.1 | 11.4 | 5.6 | 2.3 | 1.6 |
| Research and Development Expenses | 49.4 | 35.2 | 30.7 | 23.9 | 10.8 | 8.4 |
| Operating Income | (52.0) | (47.3) | (42.1) | (29.4) | (13.1) | (10.0) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0.5 | 0.4 | 0.3 | 0.3 | 65 K | 0 |
| Total Other Income | 4.1 | 1.1 | (0.2) | (0.1) | 19 K | 0.1 |
| Pre-Tax Income | (47.9) | (46.2) | (42.3) | (29.5) | (13.1) | (9.9) |
| NET INCOME | ||||||
| Tax Provision | 0 | (1.1) | 0.4 | 0.5 | 0.1 | 0.1 |
| Net Income | (47.9) | (45.1) | (42.7) | (30.0) | (13.2) | (9.9) |
| EPS | 1.24 | 1.92 | 1.83 | 1.29 | 0.59 | 2.01 |